Literature DB >> 22127066

Cellular lipid extraction for targeted stable isotope dilution liquid chromatography-mass spectrometry analysis.

Stacy L Gelhaus1, A Clementina Mesaros, Ian A Blair.   

Abstract

The metabolism of fatty acids, such as arachidonic acid (AA) and linoleic acid (LA), results in the formation of oxidized bioactive lipids, including numerous stereoisomers(1,2). These metabolites can be formed from free or esterified fatty acids. Many of these oxidized metabolites have biological activity and have been implicated in various diseases including cardiovascular and neurodegenerative diseases, asthma, and cancer(3-7). Oxidized bioactive lipids can be formed enzymatically or by reactive oxygen species (ROS). Enzymes that metabolize fatty acids include cyclooxygenase (COX), lipoxygenase (LO), and cytochromes P450 (CYPs)(1,8). Enzymatic metabolism results in enantioselective formation whereas ROS oxidation results in the racemic formation of products. While this protocol focuses primarily on the analysis of AA- and some LA-derived bioactive metabolites; it could be easily applied to metabolites of other fatty acids. Bioactive lipids are extracted from cell lysate or media using liquid-liquid (l-l) extraction. At the beginning of the l-l extraction process, stable isotope internal standards are added to account for errors during sample preparation. Stable isotope dilution (SID) also accounts for any differences, such as ion suppression, that metabolites may experience during the mass spectrometry (MS) analysis(9). After the extraction, derivatization with an electron capture (EC) reagent, pentafluorylbenzyl bromide (PFB) is employed to increase detection sensitivity(10,11). Multiple reaction monitoring (MRM) is used to increase the selectivity of the MS analysis. Before MS analysis, lipids are separated using chiral normal phase high performance liquid chromatography (HPLC). The HPLC conditions are optimized to separate the enantiomers and various stereoisomers of the monitored lipids(12). This specific LC-MS method monitors prostaglandins (PGs), isoprostanes (isoPs), hydroxyeicosatetraenoic acids (HETEs), hydroxyoctadecadienoic acids (HODEs), oxoeicosatetraenoic acids (oxoETEs) and oxooctadecadienoic acids (oxoODEs); however, the HPLC and MS parameters can be optimized to include any fatty acid metabolites(13). Most of the currently available bioanalytical methods do not take into account the separate quantification of enantiomers. This is extremely important when trying to deduce whether or not the metabolites were formed enzymatically or by ROS. Additionally, the ratios of the enantiomers may provide evidence for a specific enzymatic pathway of formation. The use of SID allows for accurate quantification of metabolites and accounts for any sample loss during preparation as well as the differences experienced during ionization. Using the PFB electron capture reagent increases the sensitivity of detection by two orders of magnitude over conventional APCI methods. Overall, this method, SID-LC-EC-atmospheric pressure chemical ionization APCI-MRM/MS, is one of the most sensitive, selective, and accurate methods of quantification for bioactive lipids.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22127066      PMCID: PMC3308612          DOI: 10.3791/3399

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  12 in total

Review 1.  Biochemical and molecular properties of the cytochrome P450 arachidonic acid monooxygenases.

Authors:  Jorge H Capdevila; John R Falck
Journal:  Prostaglandins Other Lipid Mediat       Date:  2002-08       Impact factor: 3.072

2.  Liquid chromatography/electron capture atmospheric pressure chemical ionization/mass spectrometry: analysis of pentafluorobenzyl derivatives of biomolecules and drugs in the attomole range.

Authors:  G Singh; A Gutierrez; K Xu; I A Blair
Journal:  Anal Chem       Date:  2000-07-15       Impact factor: 6.986

3.  Electron-capture negative-ion chemical ionization mass spectrometry of lipid mediators.

Authors:  I A Blair
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

Review 4.  Potential role of the lipoxygenase derived lipid mediators in atherosclerosis: leukotrienes, lipoxins and resolvins.

Authors:  Martin Hersberger
Journal:  Clin Chem Lab Med       Date:  2010-08       Impact factor: 3.694

Review 5.  Stable-isotope dilution LC–MS for quantitative biomarker analysis.

Authors:  Eugene Ciccimaro; Ian A Blair
Journal:  Bioanalysis       Date:  2010-02       Impact factor: 2.681

Review 6.  Arachidonic acid metabolism.

Authors:  P Needleman; J Turk; B A Jakschik; A R Morrison; J B Lefkowith
Journal:  Annu Rev Biochem       Date:  1986       Impact factor: 23.643

7.  Stereochemical nature of the products of linoleic acid oxidation catalyzed by lipoxygenases from potato and soybean.

Authors:  V Nikolaev; P Reddanna; J Whelan; G Hildenbrandt; C C Reddy
Journal:  Biochem Biophys Res Commun       Date:  1990-07-31       Impact factor: 3.575

Review 8.  Phospholipase A2 and arachidonic acid in Alzheimer's disease.

Authors:  Rene O Sanchez-Mejia; Lennart Mucke
Journal:  Biochim Biophys Acta       Date:  2010-05-27

Review 9.  Polyunsaturated fatty acids and cardiovascular disease: implications for nutrigenetics.

Authors:  Hooman Allayee; Nitzan Roth; Howard N Hodis
Journal:  J Nutrigenet Nutrigenomics       Date:  2009-09-23

Review 10.  Cytochrome P450-derived eicosanoids: the neglected pathway in cancer.

Authors:  Dipak Panigrahy; Arja Kaipainen; Emily R Greene; Sui Huang
Journal:  Cancer Metastasis Rev       Date:  2010-12       Impact factor: 9.264

View more
  3 in total

1.  Untargeted metabolomics from biological sources using ultraperformance liquid chromatography-high resolution mass spectrometry (UPLC-HRMS).

Authors:  Nathaniel W Snyder; Maya Khezam; Clementina A Mesaros; Andrew Worth; Ian A Blair
Journal:  J Vis Exp       Date:  2013-05-20       Impact factor: 1.355

2.  Cellular uptake and antiproliferative effects of 11-oxo-eicosatetraenoic acid.

Authors:  Nathaniel W Snyder; Sonia D Revello; Xiaojing Liu; Suhong Zhang; Ian A Blair
Journal:  J Lipid Res       Date:  2013-08-14       Impact factor: 5.922

Review 3.  Enantioselectivity Effects in Clinical Metabolomics and Lipidomics.

Authors:  Regina V Oliveira; Ana Valéria C Simionato; Quezia B Cass
Journal:  Molecules       Date:  2021-08-28       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.